Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.
A strategic thought partner for your AI journey
Explore our latest insights and perspectives in these life science resources, news articles, and events.
Discover insights into the evolving US vaccine landscape, trends, and strategic imperatives for successful novel vaccine launches. Download now!
Putnam predicts the 15 drugs likely to be selected for the second round of Medicare Price Negotiations.
Health technology assessments (HTAs) are a crucial part of the journey to bring newly developed pharmaceuticals and medical devices to patients.
As I take a moment to reflect on the past two-plus years of our AI journey and consider the predictions I made for 2024, it’s clear that many...
Putnam experts share observations on recent global trends in the rare disease space and recommend strategies to maximize opportunities.
The Inflation Reduction Act (IRA) is likely to prompt a range of second-order effects on the pharmaceutical industry...
Are you interested in equity in health and looking to capture the wider value of your assets? Watch this webcast to find out more!
We have recently welcomed two new Principals to join our team in Philadelphia and San Fransisco.
We have recently welcomed three new Principals to join our team across New York, Switzerland, and New Jersey.
We shared micro-tutorials at ISPOR Europe on nine critical scientific and strategic topics related to HTA. Contact us to discuss more.
Putnam partnered with the client to understand the potential of the product for UC treatment to maximize its commercial impact.
To understand the dynamics of drug pricing and HTA is key to grasping the future of healthcare in Japan.
Looking to get in touch with an expert or team member?
Tell us how we can help.
